NHS rolls out 5-minute 'super-jab' for 15 cancers
a year ago
- #cancer treatment
- #NHS innovation
- #immunotherapy
- NHS introduces a 5-minute 'super-jab' for treating 15 types of cancer, the first in Europe to do so.
- The new injectable form of immunotherapy, nivolumab, reduces treatment time from up to an hour via IV drip to just 5 minutes.
- Approximately 1,200 patients in England per month could benefit from this treatment, saving over a year's worth of treatment time annually.
- The jab is preferred by patients in clinical trials for its convenience and shorter administration time.
- Around 40% of patients currently receiving IV nivolumab may be eligible for the new jab.
- The rollout is expected to save NHS staff about 1,000 hours of treatment time each month.
- The treatment comes at no extra cost to the NHS due to a negotiated agreement with the manufacturer.
- This innovation is part of NHS England's strategy to improve patient experience and free up clinical capacity.